江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 江苏长青农化股份有限公司投资者关系活动记录表 编号：2018-007 | --- | --- | |----------------|-----------------------------------------------------------------------| | | √ 特定对象调研□分析师会议□媒体采访 | | 投资者关系活动 | □业绩说明会□新闻发布会□路演活动 | | 类别 | □ 现场参观□其他（请文字说明其他活动内容） | | 参与单位名称 | 天风证券 - 吴頔；浙商证券 - 曹承安 | | 及人员姓名 | | | 时间 | 2018.4.24. 14：00-15:30 | | 地点 | 公司会议室 | | 接待人员姓名 | 副董事长：黄南章 财务总监：马长庆 董事会秘书：闵丹 证券事务代表：肖刚 | | 投资者关系活动 | 1、公司如何看待目前的市场供求关系？ | | 主要内容介绍 | 随着国家对环境保护的愈加重视，对化工行业的环保监管 | | | 日趋严格，市场供给端不论是原材料还是成品都是偏紧的状 | ...

江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 江苏长青农化股份有限公司投资者关系活动记录表 编号：2018-010 | --- | --- | --- | --- | |----------------|--------------------|---------------------------------------------------------|------------------------------------------| | | √ | 特定对象调研□分析师会议□媒体采访 | | | 投资者关系活动 | | □业绩说明会□新闻发布会□路演活动 | | | 类别 | □ | 现场参观□其他（请文字说明其他活动内容） | | | | | 易方达基金-张琦； 易方达基金-杨宗昌； 中金公司-丁匡达； | | | 参与单位名称 | 中欧博瑞 - | 蒲仁杰； 兴业证券-唐婕； 兴业证券-邓先河；从 | | | 及人员姓名 | | 容投资-陈凯茜； 敦和资产 - 梁作强 | | | 时间 | | 2018.7.11. 14:30-15:30 | | | 地点 | 公司会议 ...

江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 江苏长青农化股份有限公司投资者关系活动记录表 编号：2018-011 | --- | --- | |-------------------------|-----------------------------------------------------------| | | √ 特定对象调研□分析师会议□媒体采访 | | 投资者关系活动 | □业绩说明会□新闻发布会□路演活动 | | 类别 | □ 现场参观□其他（请文字说明其他活动内容） | | | 华泰瑞联基金-隆国华；华泰瑞联基金-何梓鹏；方正证券-蔡尚 | | | 军；天风证券-李云鹏；兴业证券-唐婕、邓先河；东方证券-倪 | | 参与单位名称 及人员姓名 | 吉、万里扬；富兰克林华美证券 - 游金智；元大投信-孙新铭； | | | 融通基金 - 赵晨；马来西亚国库控股公司-聂迪中；国信证券-梁 | | | 佳。 | | 时间 | 2018.8.22. 14:30-15:30 | | 地点 | 公司会议室 | | 接待人员姓名 | 财务总监：马长庆 董事会秘书：闵丹 证券事务代 ...

江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 江苏长青农化股份有限公司投资者关系活动记录表 编号：2021-002 | --- | --- | |-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

江苏长青农化股份有限公司 2022 年第三季度报告 证券代码：002391 证券简称：长青股份 公告编号：2022-022 江苏长青农化股份有限公司 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 江苏长青农化股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 1,161,488,276.07 | 53.64% | ...

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 2,129,324,298.73, representing a 15.46% increase compared to CNY 1,844,254,042.50 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was CNY 201,743,922.08, up 23.83% from CNY 162,922,494.86 year-on-year[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 202,154,719.10, an increase of 28.64% compared to CNY 157,145,123.68 in the previous year[23]. - The net cash flow from operating activities reached CNY 340,587,714.71, a significant increase of 222.31% from CNY 105,671,718.23 in the same period last year[23]. - Basic earnings per share were CNY 0.3089, reflecting a 25.01% increase from CNY 0.2471 in the previous year[23]. - The company's total revenue for the first half of 2022 reached CNY 2,083,346,552.65, representing a year-on-year increase of 15.59%[56]. - The pesticide segment accounted for 97.84% of total operating revenue, with a year-on-year growth of 15.59%[53]. - The company reported a net profit of 0.79 million in March 2022, maintaining a consistent performance across various financial products[133]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,495,914,764.66, a 9.19% increase from CNY 6,865,253,105.64 at the end of the previous year[23]. - The company's accounts receivable rose to CNY 1,086,954,923.60, which is 14.50% of total assets, reflecting a 7.16% increase due to seasonal sales[61]. - The inventory level stood at CNY 1,325,804,030.95, representing 17.69% of total assets, with no significant changes reported[61]. - Total liabilities amounted to CNY 2,904,704,241.97, compared to CNY 2,355,427,946.73, representing an increase of about 23.29%[164]. - The company's long-term borrowings increased to CNY 610,000,000.00 from CNY 500,000,000.00, a rise of 22%[164]. Research and Development - The company's R&D investment increased by 29.05% to ¥96,433,772.52 from ¥74,725,152.45 in the previous year[52]. - Research and development expenses increased to CNY 90,730,516.63, up 22.7% from CNY 73,908,681.61 in the previous year[170]. - The company is enhancing its research and development efforts to improve its international competitiveness in the pesticide sector[34]. - The company has successfully created 30 new pesticide varieties with independent intellectual property rights, achieving a cumulative promotion area of over 300 million mu[34]. Market Position and Strategy - The global pesticide market is expected to reach $66.703 billion in 2023, with a compound annual growth rate of 3% from 2018 to 2023[31]. - The company ranks 19th in the 2022 list of China's top 100 pesticide sales enterprises published by the China Pesticide Industry Association[35]. - The company has established a comprehensive marketing network covering all 30 provinces, municipalities, and autonomous regions in China[38]. - The company is focusing on the development of high-efficiency, low-toxicity, and low-residue new pesticides, which are expected to have a large market space[33]. Environmental Management - The company has established a comprehensive environmental management system, achieving ISO14001 certification and being recognized as a green factory in the petrochemical industry[44]. - The company has implemented a pollution prevention and control management system, ensuring compliance with national laws and regulations[95]. - The company has received no administrative penalties for environmental issues during the reporting period[101]. - The company has launched several production projects at its Hubei base, including 2,6-Diisopropylaniline with an annual output of 2,000 tons, and the Flubendiamide project with an annual output of 600 tons, which are now in production[102]. Shareholder and Equity Information - The company has not distributed cash dividends or bonus shares for the half-year period, focusing on reinvestment strategies[86]. - A cash dividend of 129.92 million yuan was distributed in June 2022, representing 20% of the distributable profits for the year as per the three-year shareholder return plan[103]. - The total number of ordinary shareholders at the end of the reporting period was 29,516[150]. - The largest shareholder, Yu Guoquan, holds 25.40% of the shares, totaling 165,013,503 shares[150]. Financial Management and Investments - The total amount of entrusted financial management is CNY 60.5 million, with no overdue amounts[130]. - The company has invested CNY 36 million in bank financial products using raised funds and CNY 24.5 million using self-owned funds[130]. - The company has ongoing structured deposit investments totaling 3,000 million CNY with a floating return rate of 3.69%, which are currently not yet due[131]. - The company plans to continue its investment strategy in structured deposits and financial products, ensuring liquidity and potential returns[131]. Risk Management - The company emphasizes the importance of risk awareness regarding industry competition, capacity expansion, and raw material price fluctuations[4]. - The company is facing industry competition risks due to the entry of international pesticide giants, which may lead to price competition and affect profit margins[77]. - Raw material costs account for approximately 70% of production costs, and fluctuations in prices could significantly impact profitability, although the company has strong cost transfer capabilities[78]. Compliance and Governance - The financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring compliance and accuracy[194]. - The company confirms its ability to continue as a going concern for at least 12 months from the reporting date[195]. - The company has not engaged in any major litigation or arbitration matters during the reporting period[115].

Financial Performance - The company's operating revenue for 2021 was approximately CNY 3.76 billion, representing a 25.15% increase compared to CNY 3.01 billion in 2020[18]. - The net profit attributable to shareholders for 2021 was approximately CNY 248.53 million, an increase of 27.48% from CNY 194.96 million in 2020[18]. - The net profit after deducting non-recurring gains and losses was approximately CNY 241.05 million, reflecting a 35.92% increase from CNY 177.35 million in 2020[18]. - The net cash flow from operating activities for 2021 was approximately CNY 428.70 million, up 23.50% from CNY 347.13 million in 2020[18]. - The total assets at the end of 2021 were approximately CNY 6.87 billion, a 20.98% increase from CNY 5.67 billion at the end of 2020[18]. - The net assets attributable to shareholders at the end of 2021 were approximately CNY 4.50 billion, a 3.31% increase from CNY 4.35 billion at the end of 2020[18]. - The basic earnings per share for 2021 were CNY 0.3785, representing a 22.73% increase from CNY 0.3084 in 2020[18]. - The weighted average return on equity for 2021 was 5.63%, an increase of 0.90% from 4.73% in 2020[18]. Revenue Breakdown - The company's total revenue for the year was approximately 3.76 billion yuan, with a quarterly breakdown showing Q1 at 735.17 million yuan, Q2 at 1.11 billion yuan, Q3 at 755.97 million yuan, and Q4 at 1.16 billion yuan[22]. - The net profit attributable to shareholders for the year was approximately 248.54 million yuan, with quarterly figures of 56.58 million yuan in Q1, 106.35 million yuan in Q2, 72.89 million yuan in Q3, and 12.72 million yuan in Q4[22]. - The pesticide segment generated ¥3,683,279,404.13, accounting for 97.84% of total revenue, with a year-on-year growth of 25.78%[73]. - Herbicide sales amounted to ¥1,523,687,310.56, a 26.48% increase from ¥1,204,706,915.15 in 2020, representing 40.47% of total revenue[76]. - Direct exports contributed ¥1,441,454,950.63, a 20.38% increase from ¥1,197,417,962.55 in 2020, accounting for 38.29% of total revenue[76]. Market Position and Strategy - The company ranks 20th among the top 100 pesticide sales companies in China according to the 2021 list published by the China Pesticide Industry Association[32]. - The company is focusing on the development of high-efficiency, low-toxicity, and low-residue new pesticides, which are expected to have significant market potential[30]. - The pesticide industry is undergoing accelerated consolidation towards larger-scale operations, driven by increased competition and environmental pressures[29]. - The company has seen a shift in global pesticide production towards emerging markets like China, which now accounts for about one-third of global pesticide production[29]. - The company is actively pursuing clean production technologies to reduce emissions and production costs, aligning with national policies on low-carbon and circular economies[31]. Research and Development - The company has successfully created 30 new pesticide varieties with independent intellectual property rights, achieving a cumulative promotion area of over 300 million mu[31]. - The company has a strong focus on independent research and development, supported by multiple patents for its products[50]. - The company has established partnerships with numerous research institutions for technological innovation and product development[57]. - The company’s total research and development investment reached ¥154,720,244.00, a 16.68% increase compared to the previous year[86]. - Research and development expenses increased by 17.08% to ¥150,321,311.41, primarily due to increased investment in new products and technologies[84]. Environmental Compliance - The company has implemented a comprehensive environmental management system, achieving ISO14001 certification[61]. - The company has invested in environmental protection measures, ensuring compliance with increasingly stringent regulations[60]. - The company has established comprehensive environmental management systems and emergency response plans to ensure compliance with pollution discharge standards[179]. - The company reported continuous emissions of particulate matter at RTO discharge point with a concentration of 22.11 mg/m3, compliant with national standards[177]. - The company has wastewater treatment capacity of 4,000 tons per day for the parent company and 2,000 tons per day for the subsidiary Jiangsu Changqing Nantong[180]. Corporate Governance - The company has established a complete independent R&D, procurement, production, and sales system, operating independently from its controlling shareholders and related enterprises[133]. - The company has a clear strategy for market expansion and product development, focusing on maintaining its competitive edge in the agricultural chemicals sector[133]. - The company has a strong emphasis on corporate governance, with a structured board and independent oversight to ensure compliance and accountability[143]. - The company has established a comprehensive performance evaluation system for senior management to determine remuneration[144]. - The company has a democratic and transparent decision-making process with a sound internal supervision and feedback system[167]. Future Outlook - Jiangsu Changqing's 2022 revenue target is set at 4.8 billion CNY, representing a 27.5% increase from 2021[116]. - The company aims to achieve a net profit growth in 2022, aligning with its revenue growth target[116]. - The company plans to enhance its internal control systems to ensure sustainable and stable development amid changing external environments[117]. - The company plans to secure funding through bank loans and capital markets to support its expansion projects[118]. - The company plans to maintain a competitive salary and benefits system to attract and retain talent[158].

江苏长青农化股份有限公司 2022 年第一季度报告全文 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 证券代码：002391 证券简称：长青股份 公告编号：2022-005 江苏长青农化股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 913,809,250.58 | 735,170,172.45 | 24.30% | | 归属于上市公司股东的净利润（元） | 80,049,689.47 | 56,577 ...

Financial Performance - The company's operating revenue for Q3 2021 was ¥755,966,949.96, representing a 7.55% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was ¥72,888,340.96, up by 6.11% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥72,791,113.21, reflecting a 13.40% increase compared to the previous year[3]. - The basic earnings per share for Q3 2021 was ¥0.1115, which is a 7.21% increase year-on-year[3]. - Net profit for Q3 2021 reached CNY 236,533,874.36, an increase of 8.5% compared to CNY 218,162,377.68 in Q3 2020[20]. - Operating profit for the period was CNY 273,993,739.14, up from CNY 262,150,637.83 in the same quarter last year, reflecting a growth of 6.9%[20]. - The total comprehensive income for the period was CNY 238,813,574.36, up from CNY 217,320,877.68 in the previous year, marking an increase of 9.1%[20]. Assets and Liabilities - The total assets at the end of Q3 2021 reached ¥6,715,161,156.46, marking an 18.33% increase from the end of the previous year[3]. - The total assets of the company reached CNY 6,715,161,156.46, up from CNY 5,674,741,428.10, reflecting an increase of 18.36%[17]. - The company reported a total liability of CNY 2,233,790,975.78, up from CNY 1,304,833,051.08, indicating a rise of 71.1%[16]. Cash Flow - The cash flow from operating activities for the year-to-date period was ¥216,294,969.46, showing a 1.17% increase compared to the same period last year[3]. - Cash flow from operating activities showed a net inflow of CNY 216,294,969.46, slightly up from CNY 213,802,638.76 in the previous year[22]. - Cash flow from investing activities resulted in a net outflow of CNY 480,515,383.46, worsening from a net outflow of CNY 339,662,238.90 in Q3 2020[23]. - Cash flow from financing activities generated a net inflow of CNY 524,163,767.44, significantly higher than CNY 98,701,899.77 in the same quarter last year[23]. Investments and Expenses - The company's construction in progress increased by 238.26% to ¥912,991,952.19, primarily due to increased investment in projects[8]. - Research and development expenses for the period were CNY 106,929,703.44, compared to CNY 97,085,320.48, an increase of 10.4%[18]. Receivables and Inventory - The company's receivables increased by 57.20% to ¥737,321,130.17, driven by increased sales during the peak season[8]. - Accounts receivable rose to CNY 737,321,130.17, compared to CNY 469,036,287.51, marking a significant increase of 57.3%[15]. - Inventory levels increased to CNY 1,291,059,191.91 from CNY 1,121,835,812.92, indicating a rise of 15.1%[15]. Borrowings - Short-term borrowings rose by 76.72% to ¥1,073,500,000.00, attributed to increased working capital loans[9]. - Short-term borrowings increased significantly to CNY 1,073,500,000.00 from CNY 607,465,393.07, a rise of 76.67%[16]. Return on Equity - The weighted average return on equity was 1.65%, a slight increase of 0.06% compared to the previous year[3].

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 1,844,254,042.50, representing a 15.12% increase compared to CNY 1,602,006,105.99 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was CNY 162,922,494.86, up 10.46% from CNY 147,489,342.38 in the previous year[19]. - The net cash flow from operating activities was CNY 105,671,718.23, an increase of 12.83% compared to CNY 93,656,063.09 in the same period last year[19]. - The total assets at the end of the reporting period were CNY 6,555,293,255.14, reflecting a 15.52% increase from CNY 5,674,741,428.10 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company were CNY 4,393,683,446.14, a slight increase of 0.91% from CNY 4,354,237,460.92 at the end of the previous year[19]. - The basic earnings per share for the reporting period was CNY 0.2471, a 1.15% increase from CNY 0.2443 in the same period last year[19]. - The diluted earnings per share increased by 10.61% to CNY 0.2471 from CNY 0.2234 in the previous year[19]. - The weighted average return on equity was 3.67%, a decrease of 0.05% compared to 3.72% in the same period last year[19]. Market and Industry Insights - The global pesticide market sales increased from $25.7 billion in 2001 to $57.5 billion in 2020, with an average annual growth rate of 4%[27]. - The crop protection pesticide market is expected to reach $66.7 billion by 2023, with a compound annual growth rate of 3% from 2018 to 2023[27]. - Herbicides accounted for approximately 44% of the global pesticide market share in 2019, while insecticides and fungicides held 27% and 25%, respectively[27]. - China accounts for about one-third of the global pesticide production, with a complete industrial system including research, production, and processing[28]. - The company ranked 20th in the 2020 China pesticide sales top 100 enterprises list and 17th in national pesticide export value[31]. Research and Development - The company focuses on the research, production, and sales of high-efficiency, low-toxicity, and low-residue pesticide products, with over 30 active ingredients and 110 formulations[32]. - The company is committed to increasing R&D investment and improving its independent innovation system to enhance international competitiveness[30]. - Research and development expenses rose by 33.18% to ¥73,908,681.61, compared to ¥55,495,623.99 in the prior year[50]. - The company emphasizes technological innovation and has formed partnerships with various research institutions to enhance its R&D capabilities[39]. Production and Capacity Expansion - The company has established a production line for 6,000 tons of glyphosate raw materials, which is expected to enter trial production in the third quarter[38]. - The company is actively advancing the construction of its Hubei production base, with projects for 2,000 tons of 2,6-diisopropyl aniline and 2,000 tons of Kungfu chrysanthemum ester entering equipment installation[38]. - The company plans to expand its production capacity, particularly in the Hubei production base, leading to an increase in construction in progress to ¥623,018,190.55[57]. Environmental Management - The company has passed the ISO 14001:2016 environmental management system certification, enhancing its environmental management practices[42]. - The company has been recognized for its environmental management, receiving multiple awards for its commitment to sustainable practices[41]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[83]. - The total emissions of sulfur dioxide from the company reached 7.69 tons, exceeding the annual limit of 194.988 tons[83]. - The company has established multiple environmental management systems and emergency response plans to comply with national regulations[84]. Financial Management and Investments - The company has approved a total external guarantee limit of CNY 100 million, with actual guarantees amounting to CNY 54.6 million, representing 12.43% of the company's net assets[116]. - Total entrusted wealth management funds amounted to ¥84.3 million, with an outstanding balance of ¥46 million[118]. - The company reported no overdue amounts for entrusted wealth management products, indicating effective management of financial assets[118]. - The company has established relationships with multiple banks for wealth management services, enhancing its investment options[120]. Shareholder and Stock Information - The company plans not to distribute cash dividends or issue bonus shares for the semi-annual period[80]. - A total of 6,359,970 restricted stocks were unlocked for 111 incentive targets as of January 13, 2021[81]. - The company repurchased and canceled 6,411,931 restricted stocks for 111 incentive targets on May 26, 2021[81]. - The total number of ordinary shareholders at the end of the reporting period was 37,113[136]. - Major shareholder Yu Guoquan held 25.24% of the shares, totaling 165,013,503 ordinary shares[136]. Corporate Governance - The annual shareholders' meeting had a participation rate of 39.47%, reflecting investor engagement in corporate governance[78]. - The company has not engaged in any major related party transactions during the reporting period[104]. - The company has not made any significant investments or cash expenditures that would affect its profit distribution policy[1].